OTOMYCIN

This brand name is authorized in Israel.

Active ingredients

The drug OTOMYCIN contains a combination of these active pharmaceutical ingredients (APIs):

1
UNII 057Y626693 - NEOMYCIN SULFATE
 

Neomycin is an aminoglycoside antibiotic and acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code.

 
Read more about Neomycin
2
UNII 04JA59TNSJ - PHENYLEPHRINE HYDROCHLORIDE
 

Phenylephrine is a sympathomimetic agent with mainly direct effects on adrenergic receptors. It has predominantly alpha adrenergic activity and is without stimulating effects on the central nervous system. The sympathomimetic effect of phenylephrine produces vasoconstriction which in turn relieves nasal congestion.

 
Read more about Phenylephrine
3
UNII DK6Y9P42IN - SODIUM PROPIONATE
 
Read more about Sodium propionate
4
UNII U3RSY48JW5 - BENZOCAINE
 

Benzocaine is a local anaesthetic of the ester type, acting to produce reversible loss of sensation by preventing or diminishing the generation and transmission of sensory nerve impulses near the site of application. Depolarisation of the neuronal membrane and ion exchange are reversibly inhibited.

 
Read more about Benzocaine

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
IL מִשְׂרַד הַבְּרִיאוּת 2081

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.